U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Approvals and Databases
  4. Drugs@FDA

Glyxambi (empagliflozin and linagliptin) tablets

Glyxambi (empagliflozin and linagliptin) tablets

Company:  Boehringer Ingelheim Pharmaceuticals, Inc.
Application No.:  206073
Approval Date: 01/30/2015

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.


Date created: April 11, 2016

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.

Back to Top